Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
William S
WS
Weintraub
D015906:Angioplasty, Balloon, Coronary / Q000191:economics; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D009204:Myocardial Revascularization / Q000191:economics; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D015607:Stents / Q000191:economics*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
D000077144:Clopidogrel; D013988:Ticlopidine; D020123:Sirolimus